Targeting Trysin-Inflammation Axis for Pancreatitis Therapy in a Humanized Pancreatitis Model

Abstract

Acute pancreatitis especially due to alcohol and smoking goes onto chronic pancreatitis which, in turn, is a risk factor for pancreatic cancer. Because only a relatively small portion of patients with alcohol abuse and smoking develop pancreatitis, it is very likely that there are genetic underlying predisposing factors that have not been discovered that explain why certain individuals develop pancreatitis. A genetic defect in the trypsinogen gene (PRSS1 gene) causing hereditary pancreatitis is now well established. We developed a transgenic mouse using a Bacterial Artificial Chromosome harboring the full-length human PRSS1 with the key mutation of hereditary pancreatitis (PRSS1R122H). During the funding year we used this novel mouse model to determine whether PRSS1R122H and heavy drinking and smoking predispose to pancreatitis. Our data so far indicates that mice expressing PRSS1R122H develop a more severe form of pancreatitis than wild type mice and recovery after pancreatitis is impaired. We are working now in understanding the mechanisms underlying the observed effects.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2017
Accession Number
AD1048421

Entities

People

  • Aurelia Lugea
  • Cheng Hu
  • Stephen J Pandol

Organizations

  • Cedars-Sinai Medical Center

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Acinar Cells
  • Biomedical Research
  • Body Weight
  • Cell Physiological Processes
  • Cells
  • Chromosomes
  • Diseases And Disorders
  • Endoplasmic Reticulum
  • Inflammation
  • Medical Personnel
  • Mutations
  • Pancreatic Diseases
  • Pancreatitis
  • Recovery
  • Risk Factors
  • Targeting
  • Trypsinogen

Fields of Study

  • Medicine

Readers

  • Immunology
  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Molecular and genetic basis of cancer.

Technology Areas

  • Biotechnology